Surveys of older populations reveal rates of senile dementia varying from 5.2% to 25%. The specialist branch of psychiatry dealing with the elderly advocates that services for these patients and their carers should predominantly be based outside hospital. The following study was conducted in Limeric
Piracetam in the treatment of cognitive impairment in the elderly
β Scribed by Barry Reisberg; Steven H. Ferris; Michael K. Schneck; Jene Corwin; Pervez Mir; Eitan Friedman; Kathleen A. Sherman; Martin McCarthy; Raymond T. Bartus
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 331 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract According to EvidenceβBasedβMedicine, any proposal for the rationale treatment of mild cognitive impairment (MCI) must be based on the results of doubleβblind, randomized clinical trials (RCTs). However, since MCI at the present time does not constitute a homogeneous clinical syndrome,
Dementia has been a major public health problem and mild cognitive impairment is considered the pre-dementia syndrome in recent years. However, there has not yet been a systematic analysis of the prevalence of mild cognitive impairment in China. Objectives: The aim of this study was to analyse the
## Abstract There are theoretical grounds for believing that scopolamineβinduced cognitive deficit may be predictive of future cognitive decline. In the present study, 22 healthy elderly volunteers were reassessed 3 years after a scopolamine challenge. Although there was little overall change in me